Bender Robert & Associates Pulse Biosciences, Inc. Transaction History

Bender Robert & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$3.67 - $8.64 $37,892 - $89,208	10,325 New	10,325 $74,000
Q2 2021 Jul 16, 2021	SELL	$16.31 - $23.64 $143,935 - $208,623	-8,825 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$22.43 - $44.27 $197,944 - $390,682	8,825 New	8,825 $209,000

5.41M

139K

84.2K

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $742M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

Stay updated on Bender Robert & Associates with notifications on news.